Current and emerging strategies to combat antimalarial resistance.


Journal

Expert review of anti-infective therapy
ISSN: 1744-8336
Titre abrégé: Expert Rev Anti Infect Ther
Pays: England
ID NLM: 101181284

Informations de publication

Date de publication:
Mar 2022
Historique:
pubmed: 6 8 2021
medline: 22 4 2022
entrez: 5 8 2021
Statut: ppublish

Résumé

Since the spread of chloroquine resistance in We reviewed past recommendations and activities to respond to resistance as well as ongoing research into new ways to stop or delay the spread of resistant parasites. Inadequate information limits the options and support for a strong, coordinated response to artemisinin partial resistance in Africa, making better phenotypic and genotypic surveillance a priority. A response to resistance needs to address factors that may have hastened the emergence and could speed the spread, including overuse of drugs and lack of access to quality treatment. New ways to use the existing treatments in response to resistance, such as multiple first-lines, are currently impeded by the limited number of drugs available.

Identifiants

pubmed: 34348573
doi: 10.1080/14787210.2021.1962291
doi:

Substances chimiques

Antimalarials 0
Folic Acid Antagonists 0
Chloroquine 886U3H6UFF

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

353-372

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Auteurs

Charlotte Rasmussen (C)

Global Malaria Programme, World Health Organization, Geneva, Switzerland.

Pedro Alonso (P)

Global Malaria Programme, World Health Organization, Geneva, Switzerland.

Pascal Ringwald (P)

Global Malaria Programme, World Health Organization, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH